Extracorporeal Membrane Oxygenation Machine Market Report, 2026
The major factors driving the growth of the ECMO machine market are the growing geriatric population and the subsequent increase in disease prevalence and favorable government regulations, investments, and initiatives. The advantages of ECMO machines have played a key part in their adoption; their speed and accuracy, as well as quick processing times. This has pushed companies to focus on product development and innovation. However, factors such as declining reimbursements, lack of infrastructure (particularly in developing and underdeveloped countries), and the potential risks are expected to hinder the growth of this market.
According to research report the global ECMO Machine Market size is expected to reach USD 673 million by 2026 from an estimated USD 531 million in 2021, at a CAGR of 4.9 % from 2021 to 2026.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255167654
Rapid growth in the global geriatric population is an important cause for the rising incidence of target diseases. According to the United Nations (UN), in 2019, there were approximately 703 million people aged 65 or older globally, and this population segment is projected to reach 1.5 billion by 2050. With the rapid growth in the geriatric population globally, the prevalence of age-associated diseases such as cardiovascular diseases, cancer, arthritis, and dementia is expected to increase as well. These diseases call for early diagnosis and improved diagnostic imaging capabilities, thereby promoting the adoption of ECMO machines among end users.
The market is segmented by by Product, Component, Patient Type (Neonates, Pediatrics and Adults), Modality Outlook (Veno-Venous, Veno-Arterio and Arterio-Venous), Applications, and Region
On the basis of applications, the Extracorporeal Membrane Oxygenation Machine Market is segmented into respiratory, cardiac and ECPR applications. The respiratory segment is expected to dominate this market during the forecast period. Growth in this market can be attributed to the increasing prevalence of target diseases, high demand for early diagnosis and diagnostic imaging, and technological advancements in the ECMO machine market. Moreover, the rising prevalence of lung diseases like tuberculosis, thoracic malignancies, osteoporosis, fractures, and CVDs increases the demand for medical imaging for diagnosis.
On the basis of modality, the Extracorporeal Membrane Oxygenation Machine Market is segmented into veno-arterio, veno-venous and arterio-venous. The arterio-venous segment accounted for the larger market share. The advantages associated with this segment, such as effective dynamic range, better medical evaluation, are contributing to the growth of this technology segment.
The ECMO machine market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East Africa. North America is the largest regional market for ECMO machines, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.
Request For Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=255167654
The key growth strategies adopted by the top players in the market include product launches and approvals, agreements, expansions, and acquisitions. Product approvals and launches were the most widely adopted growth strategies by market players in the last three years to garner a larger share of the market. The Extracorporeal Membrane Oxygenation Machine Market is dominated by Fresenius Medicalcare AG Co. KGAA(Germany), Getinge Group (Sweden), Medtronic plc (US), and Microport (China).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com